Comparison of antioxidant activity and bioavailability of tea epicatechins with their epimers

British Journal of Nutrition

Volumn 91, Issue 6, 2004, Pages 873-881

  Xu, Jin Ze ^a   Yeung, Sai Ying Venus ^a   Chang, Qi ^a   Huang, Yu ^a   Chen, Zhen Yu ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Catechin; Epicatechin; Epigallocatechin; Epimerisation; Gallocatechin; Tea drinks

Indexed keywords

1,1 DIPHENYL 2 PICRYLHYDRAZYL; CATECHIN; CATECHIN GALLATE; EPICATECHIN; EPICATECHIN GALLATE; EPIGALLOCATECHIN; EPIGALLOCATECHIN GALLATE; FERRIC ION; FREE RADICAL; GALLOCATECHIN; GALLOCATECHIN GALLATE; GREEN TEA EXTRACT; LOW DENSITY LIPOPROTEIN; PLANT MEDICINAL PRODUCT; POLYPHENOL; UNCLASSIFIED DRUG; ANTIOXIDANT; BIPHENYL DERIVATIVE; DIPHENYL P PICRYLHYDRAZYL; DIPHENYL-P-PICRYLHYDRAZYL; HYDRAZINE DERIVATIVE; IRON; SCAVENGER; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ANIMAL EXPERIMENT; ANTIOXIDANT ACTIVITY; ARTICLE; AUTOCLAVE; COLUMN CHROMATOGRAPHY; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG EFFICACY; DRUG ISOLATION; DRUG MIXTURE; DRUG POTENCY; DRUG PURIFICATION; DRUG STRUCTURE; EPIMER; EPIMERIZATION; FOOD PROCESSING; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VITRO STUDY; INTERMETHOD COMPARISON; LIPID OXIDATION; MALE; NONHUMAN; PRECURSOR; RAT; REDUCTION; STATISTICAL SIGNIFICANCE; TEA; TEMPERATURE; TIME; ANIMAL; BIOAVAILABILITY; CHEMISTRY; COMPARATIVE STUDY; HUMAN; METABOLIC CLEARANCE RATE; METABOLISM; SPRAGUE DAWLEY RAT;

ANIMALS; ANTIOXIDANTS; BIOLOGICAL AVAILABILITY; BIPHENYL COMPOUNDS; CATECHIN; FREE RADICAL SCAVENGERS; HUMANS; HYDRAZINES; IRON; LIPOPROTEINS, LDL; MALE; METABOLIC CLEARANCE RATE; RATS; RATS, SPRAGUE-DAWLEY; TEA; THIOBARBITURIC ACID REACTIVE SUBSTANCES;

EID: 3142590790     PISSN: 00071145     EISSN: None     Source Type: Journal    
DOI: 10.1079/BJN20041132     Document Type: Article

References (22)

1. Ahmad N & Mukhtar H (1999) Green tea polyphenols and cancer: Biological mechanisms and practical implications. Nutr Rev 57, 78-83.
2. Benzie IFF & Strain JJ (1999) Ferric reducing antioxidant power assay: direct measurement of total antioxidant activity of biological fluids and modified version for simultaneous measurement of total antioxidant power and ascorbic acid concentration. Methods Enzymol 299, 15-27.
3. Blois MS (1958) Antioxidant determination by the use of a stable free radical. Nature 181, 1199-1200.
4. Chen LS, Lee MJ, Li H & Yang CS (1997) Absorption, distribution and elimination of tea polyphenols in rats. Drug Metab Dispos 25, 1045-1050.
5. Chen ZY, Zhu QY, Tsang D & Huang Y (2001) Degradation of green tea catechins in tea drinks. J Agric Food Chem 49, 477-482.
6. Duffy SJ, Keaney JF Jr, Holbrook M, Gokce N, Swerdloff PL, Frei B & Vita JA (2001) Short- and long-term black tea consumption reverses endothelial dysfunction in patients with coronary heart disease. Circulation 104, 151-156.
7. Hertog MGL, Feskens EJM, Hollman PCH, Katan MB & Kromhout D (1993) Dietary antioxidant flavonoids and risk of coronary heart disease: The Zutphen Elderly Study. Lancet 342, 1007-1011.
8. Hodgson JM, Puddey IB, Burke V, Watts GE & Beilin LJ (2002) Regular ingestion of black tea improves brachial artery vasodilator function. Clin Sci 102, 195-201.
9. Huang Y, Chan NWK, Lau CW, Yao XQ, Chan FL & Chen ZY (1999) Involvement of endothelium/nitric oxide in vasorelaxation induced by purifed green tea (-)-epicatechin. Biochim Biophys Acta 1427, 322-328.
10. Imai K & Nakachi K (1995) Cross sectional study of effects of drinking green tea on cardiovascular and liver disease. Br Med J 310, 693-696.
11. Kono S, Shinchi K, Ikeda N, Yanai F & Imanishi K (1992) Green tea consumption and serum lipid profile: a cross-sectional study in Northern Kyush. Jpn Prev Med 21, 526-531.
12. Leenen R, Roodenburg AJ, Tijburg L & Wiseman SA (2000) A single dose of tea with or without milk increases plasma antioxidant activity in humans. Eur J Clin Nutr 54, 87-92.
13. Lowry OH, Rosebrough NJ, Farr AL & Randall R (1951) Protein measurement with the Folin-phenol reagent. J Biol Chem 193, 265-275.
14. Pahl H, Wang G & Esterbauer H (1994) Methods to determine oxidation of low-density lipoproteins. Methods Enzymol 233, 425-434.
15. Spencer JPE (2003) Metabolism of tea flavonoids in the gastrointestinal tracts. J Nutr 133, 3255S-3261S.
16. Stensvold I, Tverdal A, Solvoll K & Foss DP (1992) Tea consumption. Relationship to cholesterol, blood pressure, and coronary and total mortality. Prev Med 21, 546-553.
17. Wiseman S, Weisgerber U, Tijburg L & Korver O (1999) The food industry and functional foods: Tea antioxidant and cardiovascular disease. In Antioxidant Food Supplements in Human Health, pp. 445-460 [L Packer, M Hiramatsu and T Yoshikawa, editors]. San Diego, CA: Academic Press.
18. Young W, Hotovec RL & Romero AG (1967) Tea and atherosclerosis. Nature 216, 1015-1016.
19. Xu JZ, Leung LK, Huang Y & Chen ZY (2003) Epimerisation of tea polyphenols in tea drinks. J Sci Food Agric 83, 1617-1621.
20. Zhang A, Chan PT, Luk YS, Ho WKK & Chen ZY (1997) Inhibitory effect of jasmine green tea epicatechin isomers on LDL-oxidation. J Nutr Biochem 8, 334-340.
21. Zhu M, Chen Y & Li RC (2000) Oral absorption and bioavailability of tea catechins. Planta Med 66, 444-447.
22. Zhu QY, Zhang A, Tsang D, Huang Y & Chen ZY (1997) Stability of green tea catechin. J Agric Food Chem 45, 4624-4628.